Quantcast
Last updated on April 24, 2014 at 21:24 EDT

Latest Drugs Stories

2013-12-03 12:25:52

Strategic Alliance to Provide Seamless Services from Cell Line Development to cGMP Manufacturing of Biologic Drugs HSINCHU, Taiwan and GENEVA, Dec. 3, 2013 /PRNewswire/ -- JHL Biotech, Inc., a provider of biopharmaceutical process development and manufacturing services, and Switzerland-based Selexis SA, a provider of technologies for mammalian cell line development, announced today that they have signed a non-exclusive strategic agreement to provide biopharmaceutical customers a seamless...

2013-12-02 08:31:02

New Six-Year Agreement Marks the First GPO Contract for ICU Medical's Breakthrough Automated Sterile Compounding System for the Accurate, Safe, and Efficient Preparation of Hazardous Drugs, Set to Debut at ASHP Midyear in Orlando, December 8-12 SAN CLEMENTE, Calif., Dec. 2, 2013 /PRNewswire/ -- ICU Medical Inc. (NASDAQ: ICUI) today announced it has been awarded a six-year group purchasing contract from Premier Inc. for the Diana(TM) hazardous drug compounding system, the world's...

2013-11-27 12:24:07

DUBLIN, November 27, 2013 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/7lgrpn/flatrate) has announced the addition of the "Flat-Rate Subscription to La Merie Publishing Reports" [http://www.researchandmarkets.com/research/7lgrpn/flatrate ] to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) This subscription provides access during one year to all existing and new reports produced by La Merie Publishing...

2013-11-26 23:23:41

Patients with diabetes receiving prescribed heart medications through mail-service pharmacies are less likely to visit the emergency room than patients getting their medication at drugstores, according to a new Kaiser Permanente study Washington D.C. (PRWEB) November 26, 2013 Patients with diabetes receiving prescribed heart medications through mail-service pharmacies are less likely to visit the emergency room than patients getting their medication at drugstores, according to a new...

2013-11-22 04:21:00

DUBLIN, Nov. 22, 2013 /PRNewswire/ -- The Alliance for Safe Biologic Medicines (ASBM) today released the results of a new survey on European physicians' views on biosimilar naming. ASBM Executive Director Michael Reilly presented the findings at the Drug Information Association (DIA) Biosimilars Workshop in Dublin, Ireland. The key findings showed that nonproprietary names matter to patient safety. The survey examined responses from more than 470 prescribers located in the United Kingdom,...

2013-11-21 23:31:43

With millions of Americans abusing prescription drugs and rates of fatal overdose soaring, many doctors struggle with how to provide their patients needed medicine without feeding the addiction epidemic. SIMmersion's Prescription Drug and Pain Management Training Simulation, created in partnership with researchers at Northwestern University and the University of Wisconsin—Madison, trains doctors in patient-centered techniques to address the prescription drug crisis without...

2013-11-20 23:04:55

Reportbuyer.com just published a new market research report: The Worldwide Pharmaceutical Market Forecast to 2018. London (PRWEB) November 20, 2013 This analysis report is an essential resource for business forecasters, marketing planners, the investment community and anyone looking to understand the future outlook for the dynamic pharmaceutical industry. With this report you have instant access to thousands of market projections and ranking to inform and direct your future operations....

2013-11-20 12:24:46

IRVING, Texas, Nov. 20, 2013 /PRNewswire/ -- Health systems professionals should prepare now for the introduction of biosimilars, a new category of pharmaceuticals intended to offer lower cost alternatives for some of the most expensive medications purchased by health care organizations. This insight comes from newly published research co-authored by Novation, the leading health care supply chain expertise, analytics and contracting company. The primer, "Biosimilars: Implications...

2013-11-19 23:32:27

Due to increasing demand for acne treatments, the Prescription Acne Treatment Manufacturing industry has exhibited positive growth during the five years to 2013. For this reasons, industry research firm IBISWorld has updated a report on the Prescription Acne Treatment Manufacturing industry in its growing industry report collection. Los Angeles, CA (PRWEB) November 19, 2013 Acne remains a common skin disorder experienced by teenagers and adolescents, affecting about 40 million to 50...

2013-11-19 08:28:49

MARGATE CITY, N.J., Nov. 19, 2013 /PRNewswire/ -- The slow, rocky beginnings of the Affordable Care Act (ACA) have raised concerns about what might happen if millions of people choose to remain uninsured. The early numbers paint a troubling picture -- not enough people are signing up through the Health Insurance Marketplaces to make the program sustainable. For those that go without insurance, Medicationdiscountcard.com provides a backup for dealing with at least one aspect of...